majority of intellectual property litigation stems from the interplay between generic or imitator drug and brand name or …

This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is … also characterized by extensive regulation of almost every activity, from product development through manufacturing and …-patent “generic” drugs has had an important impact on the market structure of the industry. The last two decades have seen a shift …

Understanding the drivers of market concentration in the generic pharmaceutical industry is essential to guaranteeing … markets would still lack generic competition …

This paper examines generic entry into the Japanese pharmaceutical market. Relatively little is known about generic … entry in regulated markets. Using micro data between 2003 and 2005, I find that generic entry is sensitive to the … prescription pattern driven by the price regulation and healthcare system. Fewer generics enter if the drug is more frequently …